Your browser doesn't support javascript.
loading
Brain MR patterns in inherited disorders of monoamine neurotransmitters: An analysis of 70 patients.
Kuseyri Hübschmann, Oya; Mohr, Alexander; Friedman, Jennifer; Manti, Filippo; Horvath, Gabriella; Cortès-Saladelafont, Elisenda; Mercimek-Andrews, Saadet; Yildiz, Yilmaz; Pons, Roser; Kulhánek, Jan; Oppebøen, Mari; Koht, Jeanette Aimee; Podzamczer-Valls, Inés; Domingo-Jimenez, Rosario; Ibáñez, Salvador; Alcoverro-Fortuny, Oscar; Gómez-Alemany, Teresa; de Castro, Pedro; Alfonsi, Chiara; Zafeiriou, Dimitrios I; López-Laso, Eduardo; Guder, Philipp; Santer, René; Honzík, Tomás; Hoffmann, Georg F; Garbade, Sven F; Sivri, H Serap; Leuzzi, Vincenzo; Jeltsch, Kathrin; García-Cazorla, Angeles; Opladen, Thomas; Harting, Inga.
Affiliation
  • Kuseyri Hübschmann O; Department of Child Neurology and Metabolic Disorders, University Children's Hospital, Heidelberg, Germany.
  • Mohr A; Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany.
  • Friedman J; UCSD Departments of Neuroscience and Pediatrics; Rady Children's Hospital Division of Neurology, Rady Children's Institute for Genomic Medicine, San Diego, California, USA.
  • Manti F; Unit of Child Neurology and Psychiatry, Department of Human Neuroscience, Sapienza, University of Rome, Rome, Italy.
  • Horvath G; University of British Columbia, Department of Pediatrics, Division of Biochemical Genetics, BC Children's Hospital, Vancouver, British Columbia, Canada.
  • Cortès-Saladelafont E; Inborn Errors of Metabolism Unit, Department of Neurology, Institut de Recerca Sant Joan de Déu and CIBERER-ISCIII, Barcelona, Spain.
  • Mercimek-Andrews S; Unit of Pediatric Neurology and Metabolic Disorders, Department of Pediatrics, Hospital Germans Trias i Pujol and Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Yildiz Y; Division of Clinical and Metabolic Genetics, Department of Pediatrics, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Pons R; Faculty of Medicine, Department of Pediatrics, Section of Metabolism, Hacettepe University, Ankara, Turkey.
  • Kulhánek J; First Department of Pediatrics of the University of Athens, Aghia Sofia Hospital, Athens, Greece.
  • Oppebøen M; Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Koht JA; Children's Department, Division of Child Neurology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Podzamczer-Valls I; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Domingo-Jimenez R; Department of Neurology, Neurometabolic Unit, and Synaptic Metabolism Laboratory, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.
  • Ibáñez S; Universitat de Barcelona, Barcelona, Spain.
  • Alcoverro-Fortuny O; Department of Pediatric Neurology, Hospital Virgen de la Arrixaca, Murcia, Madrid, Spain.
  • Gómez-Alemany T; IMIB-Arrixaca, Murcia, CIBERER-ISCIII, Madrid, Spain.
  • de Castro P; Department of Pediatric Neurology, Hospital Virgen de la Arrixaca, Murcia, Madrid, Spain.
  • Alfonsi C; Service of Psychiatry, Hospital Benito Menni - Hospital General de Granollers, Barcelona, Spain.
  • Zafeiriou DI; Service of Psychiatry, Hospital Benito Menni - Hospital General de Granollers, Barcelona, Spain.
  • López-Laso E; Department of Pediatric Neurology, Hospital Gregorio Marañón, Madrid, Spain.
  • Guder P; Inborn Errors of Metabolism Unit, Department of Neurology, Institut de Recerca Sant Joan de Déu and CIBERER-ISCIII, Barcelona, Spain.
  • Santer R; Department of Human Neuroscience, Sapienza, University of Rome, Rome, Italy.
  • Honzík T; Child Neurology and Developmental Pediatrics, 1st Department of Pediatrics, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Hoffmann GF; Pediatric Neurology Unit, Department of Pediatrics, University Hospital Reina Sofía, IMIBIC and CIBERER, Córdoba, Spain.
  • Garbade SF; Department of Pediatrics, UKE, Hamburg.
  • Sivri HS; Department of Pediatrics, UKE, Hamburg.
  • Leuzzi V; Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Jeltsch K; Department of Child Neurology and Metabolic Disorders, University Children's Hospital, Heidelberg, Germany.
  • García-Cazorla A; Department of Child Neurology and Metabolic Disorders, University Children's Hospital, Heidelberg, Germany.
  • Opladen T; Faculty of Medicine, Department of Pediatrics, Section of Metabolism, Hacettepe University, Ankara, Turkey.
  • Harting I; Department of Child Neurology and Metabolic Disorders, University Children's Hospital, Heidelberg, Germany.
J Inherit Metab Dis ; 44(4): 1070-1082, 2021 07.
Article in En | MEDLINE | ID: mdl-33443316
Inherited monoamine neurotransmitter disorders (iMNDs) are rare disorders with clinical manifestations ranging from mild infantile hypotonia, movement disorders to early infantile severe encephalopathy. Neuroimaging has been reported as non-specific. We systematically analyzed brain MRIs in order to characterize and better understand neuroimaging changes and to re-evaluate the diagnostic role of brain MRI in iMNDs. 81 MRIs of 70 patients (0.1-52.9 years, 39 patients with tetrahydrobiopterin deficiencies, 31 with primary disorders of monoamine metabolism) were retrospectively analyzed and clinical records reviewed. 33/70 patients had MRI changes, most commonly atrophy (n = 24). Eight patients, six with dihydropteridine reductase deficiency (DHPR), had a common pattern of bilateral parieto-occipital and to a lesser extent frontal and/or cerebellar changes in arterial watershed zones. Two patients imaged after acute severe encephalopathy had signs of profound hypoxic-ischemic injury and a combination of deep gray matter and watershed injury (aromatic l-amino acid decarboxylase (AADCD), tyrosine hydroxylase deficiency (THD)). Four patients had myelination delay (AADCD; THD); two had changes characteristic of post-infantile onset neuronal disease (AADCD, monoamine oxidase A deficiency), and nine T2-hyperintensity of central tegmental tracts. iMNDs are associated with MRI patterns consistent with chronic effects of a neuronal disorder and signs of repetitive injury to cerebral and cerebellar watershed areas, in particular in DHPRD. These will be helpful in the (neuroradiological) differential diagnosis of children with unknown disorders and monitoring of iMNDs. We hypothesize that deficiency of catecholamines and/or tetrahydrobiopterin increase the incidence of and the CNS susceptibility to vascular dysfunction.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain / Magnetic Resonance Imaging / Amino Acid Metabolism, Inborn Errors Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Language: En Journal: J Inherit Metab Dis Year: 2021 Document type: Article Affiliation country: Germany Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain / Magnetic Resonance Imaging / Amino Acid Metabolism, Inborn Errors Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Language: En Journal: J Inherit Metab Dis Year: 2021 Document type: Article Affiliation country: Germany Country of publication: United States